| Brand Name | LIVONGO BLOOD GLUCOSE MONITORING SYSTEM |
| Common Device Name | SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER |
| Manufacturer (Section D) |
| ACON LABORATORIES, INC/LIVONGO HEALTH |
| |
|
| MDR Report Key | 10843181 |
| Report Number | MW5097874 |
| Device Sequence Number | 1153980 |
| Product Code |
NBW
|
| UDI-Device Identifier | 00853553005004 |
| UDI-Public | (01)00853553005004 |
| Initial Reporter State | VA |
| Initial Reporter Country | US |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Reporter Type |
Voluntary
|
| Initial Reporter Occupation |
Patient
|
| Type of Report
| Initial |
| Report Date (Section B) |
11/11/2020 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
Yes
|
| Operator of Device |
Lay User/Patient
|
| Device Expiration Date | 11/21/2021 |
| Device Model Number | BG300 |
| Device Catalogue Number | OFG00406 |
| Device Lot Number | 890973 |
| Was Device Available for Evaluation? |
Yes
|
| Initial Date Received by Manufacturer | Not provided |
| Initial Report FDA Received Date | 11/13/2020 |
| Patient Sequence Number | 1 |
| Outcome Attributed to Adverse Event |
Other;
|
| Patient Age | 62 YR |
| Patient Weight | 84 |
|
|